8 results
Clinical Pharmacologic Properties of Antiarrhythmic Drugs

#Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table #Effects
Clinical Pharmacologic ... Drugs #Antiarrhythmic ... #Drugs #Medications ... Cardiology #Table ... #Effects
Antiarrhythmic Medications - Vaughan-Williams Classification
 • Class I (Ia, Ib, Ic)
 • Class II
 • Class
- Vaughan-Williams ... Classification ... drugs: Adenosine ... #pharmacology # ... cardiology
Antiarrhythmic Medications - Vaughan-Williams Classification
 • Class I (Ia, Ib, Ic)
 • Class II
 • Class
- Vaughan-Williams ... Classification ... drugs: Adenosine ... #pharmacology # ... cardiology
Antiarrhythmic Drugs

CLASS IA
 • Procainamide, Quinidine, Disopyramide
CLASS 1B
 • Lidocaine, Mexiletine
CLASS 2
 • Propranolol, Esmolol
CLASS 4
Antiarrhythmic Drugs ... #Medications #Classes ... #Classification ... #Pharmacology # ... cardiology
Drugs affecting the cardiac action potential. The sharp rise in voltage ("0") corresponds to the influx
Drugs affecting ... #Pathophys #Pharmacology ... #Cardiology #Antiarrhythmics ... #Classes #Effect
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
Antiarrhythmics ... - Vaughan Williams ... Classification: ... channel blocking effects ... #Pharmacology #
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Cardiovascular Drug-Drug ... vera, Licorice - Causes ... arrhythmias Class I Antiarrhythmic ... Drugs • Echinacea ... #DDI #table #cardiology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics ... Pharmacology Summary ... Vaughan Williams ... Classification: ... channel blocking effects